Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?

MLA

Scheid, Christof, et al. “Does IPSS-R Downstaging before Transplantation Improve the Prognosis of Patients with Myelodysplastic Neoplasms?” Blood, vol. 144, no. 4, July 2024, pp. 445–56. EBSCOhost, https://doi.org/10.1182/blood.2023022273.

APA

Scheid, C., Eikema, D.-J., van Gelder, M., Salmenniemi, U., Maertens, J., Passweg, J., Blaise, D., Byrne, J. L., Kröger, N., Sockel, K., Chevallier, P., Bourhis, J. H., Cornelissen, J. J., Sengeloev, H., Finke, J., Snowden, J. A., Gedde-Dahl, T., Cornillon, J., Schanz, U., … Yakoub-Agha, I. (2024). Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? Blood, 144(4), 445–456. https://doi.org/10.1182/blood.2023022273

Chicago

Scheid, Christof, Diderik-Jan Eikema, Michel van Gelder, Urpu Salmenniemi, Johan Maertens, Jakob Passweg, Didier Blaise, et al. 2024. “Does IPSS-R Downstaging before Transplantation Improve the Prognosis of Patients with Myelodysplastic Neoplasms?” Blood 144 (4): 445–56. doi:10.1182/blood.2023022273.